Hogan Lovells Represents GE in Acquisition of Strategic Assets from Thermo Fisher Scientific

WASHINGTON, D.C. 9 January 2014 – Hogan Lovells represented GE Healthcare in connection with its agreement to acquire Thermo Fisher Scientific’s HyClone™ cell culture media and sera, gene modulation and magnetic beads businesses for approximately US$1.06 billion. The businesses will become part of GE Healthcare's Life Sciences division. The deal was announced on 6 January, 2014.

Hogan Lovells Washington, D.C. partners Joseph Gilligan and Paul Manca led the multidisciplinary team advising GE Healthcare with assistance from Warren Gorrell (Co-CEO, Washington, D.C.) and other partners and counsel from the corporate, regulatory, intellectual property, tax, environmental, real estate, employment and employee benefits groups, including:  Christine Burke, Celine Crowson, Dan Davidson, Beth Peters, Randy Prebula, Audrey Reed, Scott Reisch, Anthony Ryan, Amit Saluja, Martha Steinman, T. Weymouth and Michael Williams.


Share Back To Listing

Loading data